CARLSBAD, Calif., July 28: DCN Dx, a Carlsbad, California-based in vitro diagnostics (IVD) services company that supports a diagnostic’s path from concept to commercial success, today announced the appointment of Trevor Brown as chief revenue officer.
The hire adds deep industry expertise to DCN Dx’s commercial organization and executive leadership team. Brown will be accountable for overall commercial strategy, sales, marketing and client growth across the company’s three connected businesses: assay development and manufacturing; IVD-focused clinical trials and regulatory support; and biospecimen sourcing.
Brown brings more than 20 years of commercial leadership across diagnostics, precision medicine and life sciences, having held senior roles at LASE Innovation, LUMICKS, Spartan Bioscience, SeraCare Life Sciences, Luminex and BD. He has launched multiple FDA-cleared and CE-marked IVDs and has scaled teams from early-stage startups to private equity-backed organizations, resulting in successful exits.
“We are really excited to have Trevor join DCN,” said Charlie Mamrak, CEO of DCN Dx. “He brings a deep understanding of diagnostics and the entire pathway from idea to commercialization, and understands the challenges our customers face along the entire journey. He is ideally suited to lead DCN’s next phase of growth as we leverage our full suite of business services to accelerate the next era of diagnostics.”
“I joined DCN because of the unique mission we have—helping our partners bring game-changing diagnostics to market by derisking the process, reducing their costs and enabling their commercial success,” said Brown. “At DCN, we have an entire team of diagnostic industry experts who’ve developed assays, designed and run trials, and built comprehensive biospecimen sourcing networks, with the sole purpose of accelerating the time to market for our partners.”